Coming nearly two years after the company’s $100 million Series C, Biofourmis tallied its total raise at $445 million.
Biofourmis reaches unicorn status with $300M Series D
Coming nearly two years after the company’s $100 million Series C, Biofourmis tallied its total raise at $445 million.
